Where do we stand on quality of life?
Worldwide, several thousand diseases affect humans, of which only about five hundred have any treatment. More than seven hundred million people suffer from malnutrition. Health care for aging people and related diseases concern more than one billion people. And more such issues are at stake.
With you and our partners, our vision and our values, we have the ambition to create, with the ‘Health from Space’ conference, a platform for the accelerated discoveries of therapies and advances in quality of life, for individuals as well as humankind globally.
Indeed, the life sciences, health, and related biomaterial domains are on the verge of a disruptive evolution, actually a revolution, thanks to the possibility of establishing and operating facilities in the environment of space.
Oddly enough, most of the actors in these domains are unaware of these coming dramatic changes. It will happen that, even though the pharmaceutical and cosmetics industries can be considered fully mature—with turnovers each of more than one trillion per year and hundreds of millions of dollars in research and development annually—the new environment offered by space is poised to dramatically impact those numbers positively.
The potential scientific, technological, and commercial benefits of microgravity research, development, and manufacturing in space are considerable. They will revolutionize traditional Earth-bound development and processing methods for these whole sectors:
- Cosmetics
- Medical research
- Biotechnology
- Biomaterials
This revolution will stem both from easier access to space—in terms of cost and flight opportunities—and from the new space platforms and private stations planned to be launched worldwide.
Together with the new advanced and miniaturized laboratories, these will provide researchers and industry alike with exceptional opportunities to conduct experiments in a disruptive microgravity environment, meeting scientific and manufacturing principal standards.
The resulting number of applications is expected to increase drastically, from:
- New therapeutics
- Anti-aging treatments
- Regenerative medicine
- Stem cell research
The whole pharmaceutical, cosmetics, medical, biotechnology, and biomaterial industries will become major participants in the frame of the commercialization of space.
As key actors in these domains, we invite you to attend this high-level event, which is expected to gather several hundred participants, including:
- Worldwide experts and investors
- CEOs and C-Level executives from Pharma, Cosmetics, Biotechnology, Nutrition, Medical, and Advanced Biomaterials industries
- Heads of Scientific Institutions and Space Agencies
- Government Officials
They will share discussions on how to foster these groundbreaking innovations
Programme détaillé disponible ici : https://www.healthfromspace.com/en/program/program
Membre Eurobiomed, contactez Alexandra Beltoise pour bénéficier d’un tarif préférentiel.
